Dermatol. praxi. 2026;20(2):65-73 | DOI: 10.36290/der.2026.011

Non-melanoma skin cancers: part I. basal cell carcinoma and squamous cell carcinoma

MUDr. Edita Marvanová
I. dermatovenerologická klinika, FN u sv. Anny v Brně a LF MU Brno

Malignant skin tumors represent a heterogeneous group consisting of melanoma as a distinct entity and the so-called non-melanoma skin cancers (NMSC). This classification is based on the different biological behaviour of individual tumors, which determines distinct therapeutic approaches. The main representatives of NMSC are basal cell carcinoma (75-80 % of NMSC) and squamous cell carcinoma (20 % of NMSC). Less common skin malignancies include Kaposi sarcoma, dermatofibrosarcoma protuberans, Merkel cell carcinoma, extramammary Paget disease, and adnexal carcinomas. Cutaneous metastases from internal malignancies may also occur. The aim of this article is to summarize current knowledge regarding the two most common non-melanoma skin cancers, with a focus on their diagnosis, clinical presentation, and therapeutic options from the dermatologist's perspective.

Keywords: basal cell carcinoma, cutaneous squamous cell carcinoma, diagnostics, treatment.

Accepted: June 8, 2026; Published: June 18, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marvanová E. Non-melanoma skin cancers: part I. basal cell carcinoma and squamous cell carcinoma. Dermatol. praxi. 2026;20(2):65-73. doi: 10.36290/der.2026.011.
Download citation

References

  1. Hernandez LE, Mohsin N, Levin N, et al. Basal cell carcinoma: An updated review of pathogenesis and treatment options. Dermatol Ther. 2022 Jun;35(6):e15501. doi: 10.1111/dth.15501. Epub 2022 Apr 12. PMID: 35393669. Go to original source... Go to PubMed...
  2. Pásek M. Bazaliom a Spinaliom. In: Moderní farmakoterapie v dermatologii. 2025; p: 459-493.
  3. Fikrle T, Pizinger K. Dermatoskopie nepigmentovaných kožních nádorů. Kožní karcinomy a aktinické keratózy. Čes-slov Derm. 2016;91(4):174-176.
  4. Available from: https://atlases.muni.cz/atlases.html.
  5. Hercogová J, Kacerovská D. Dermatohistopatologie. Česká akademie dermatovenerologie; 2020.
  6. Peris K, Fargnoli MC, Kaufmann R, et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma - update 2023. Eur J Cancer. 2023 Oct;192:113254. doi: 10.1016/j.ejca.2023.113254. Epub 2023 Jul 28. PMID: 37604067. Go to original source...
  7. Arenberger P, Ettler J. Bazaliom. Onkologie. 2016;10(2):62-65. Go to original source...
  8. Masterpol KS. Atlas of Essential Dermatohistopathology. New York: Springer; 2013. Go to original source...
  9. Bolognia JL. Actinic Keratosis, Basal Cell Carcinoma, and Squamous Cell Carcinoma. In: Bolognia JL, Schaffer JV, Cerroni L, et al. Dermatology. 5th ed. Elsevier; 2018: p. 1888-1910.
  10. Gorlin RJ, Goltz RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med. 1960;262: p. 908-912. Go to original source...
  11. Fridrichová M, Votavová K. Možnosti terapie kožních nádorů BCC a SCC, nádorů z Merkelových buněk a DFSP. Dermatol. praxi. 2024;18(2):90-96. Go to original source...
  12. Čelakovská J. Nemelanomové kožní nádory - bazaliom, spinaliom, přehled o onemocnění a léčbě. Geriatrie a Gerontologie. 2022;11(2):68-74.
  13. Fialová A. Nemelanomové kožní nádory. Onkologie. 2020;14(5):233-239. Go to original source...
  14. Kandolf L, Peris K, Malvehy J, et al., European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):1024-1047. doi: 10.1111/jdv.19897. Epub 2024 Mar 7. PMID: 38451047. Go to original source...
  15. Stratigos AJ, Garbe C, Dessinioti C, L et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023. Eur J Cancer. 2023 Nov;193:113252. doi: 10.1016/j.ejca.2023.113252. Epub 2023 Jul 28. PMID: 37708630. Go to original source...
  16. Pink A, Anzengruber F, Navarini A, et al. Squamous cell carcinoma arising within hidradenitis suppurativa: a literature review. Int J Dermatol. 2021;60(11):e459-e465. doi: 10.1111/ijd.15677. Go to original source...
  17. Lin YH, Wang YC, Chen TL, et al. Association Between Prurigo Nodularis and Malignancy: A Real-World Multicenter Retrospective Cohort Study. J Dermatol. 2026 Feb;53(2):281-287. doi: 10.1111/1346-8138.70112. Epub 2025 Dec 12. PMID: 41387104. Go to original source... Go to PubMed...
  18. Hyeraci M, Didona D, Abeni D, et al. New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review. Int J Mol Sci. 2025 Oct 15;26(20):10040. doi: 10.3390/ijms262010040. PMID: 41155332; PMCID: PMC12562887. Go to original source... Go to PubMed...
  19. Savage JA, Maize Sr. JC. Keratoacanthoma clinical behavior: a systematic review. Am J Dermatopathol. 2014 May;36(5):422-9. doi: 10.1097/DAD.0000000000000031. PMID: 24366198. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.